<DOC>
	<DOCNO>NCT02164045</DOCNO>
	<brief_summary>The current food effect study perform support Phase 3 study BMS 663068 . Results study inform whether patient upcoming Phase 3 study give flexibility dose BMS-663068 fast state , desire .</brief_summary>
	<brief_title>Study Evaluate Effect Food Pharmacokinetics BMS-626529</brief_title>
	<detailed_description>Primary Purpose : Other : To assess effect food steady-state exposure BMS-626529 administer BMS 663068 600 mg twice daily ( BID ) healthy subject Acquired Immune Deficiency Syndrome ( AIDS )</detailed_description>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy subject determine clinically significant deviation normal medical surgical history , physical examination finding , 12lead ECG measurement , clinical laboratory test result Body mass index ( BMI ) 18.0 32.0 kg/m2 , inclusive Males Females , age 18 50 year , inclusive Women childbearing potential ( WOCBP ) must negative serum urine pregnancy test ( minimum sensitivity 25 IU/L equivalent unit human chorionic gonadotropin ( HCG ) ) within 24 hour prior start study drug Any significant acute chronic medical illness determine investigator Current recent ( within 3 month study drug administration ) gastrointestinal disease could impact upon absorption study drug Any major surgery within 4 week study drug administration Any gastrointestinal surgery could impact upon absorption study drug Inability tolerate oral medication Recent ( within 6 month study drug administration ) history smoke current smoker Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , electrocardiogram ( ECG ) clinical laboratory determination beyond consistent target population Any follow 12lead ECG prior study drug administration , confirm repeat ) PR ≥ 210 msec ii ) QRS ≥ 120 msec iii ) QT ≥ 500 msec iv ) QTcF ≥ 450 msec b ) Positive urine screen drug abuse Positive blood screen hepatitis C antibody , hepatitis B surface antigen , Human Immunodeficiency Virus1 ( HIV1 ) , 2 antibody , HIV1 RNA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>